KODIAK SCIENCES INC. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- KODIAK SCIENCES INC. stock issued during period, value, new issues for fiscal 2025 was $172.66M.
- KODIAK SCIENCES INC. stock issued during period, value, new issues for fiscal 2020 was $612.02M, a 105.64% increase from fiscal 2019.
- KODIAK SCIENCES INC. stock issued during period, value, new issues for fiscal 2019 was $297.62M, a 256.60% increase from fiscal 2018.
- KODIAK SCIENCES INC. stock issued during period, value, new issues for fiscal 2018 was $83.46M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2025-12-31 | $172.66M 10-K · filed 2026-03-31 | |
| 2020-12-31 | $612.02M 10-K · filed 2023-03-28 | |
| 2019-12-31 | $297.62M 10-K · filed 2022-03-01 | |
| 2018-12-31 | $83.46M 10-K · filed 2021-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |